Announcement

Collapse
No announcement yet.

Utility of Pandemic H1N1-09 Influenza Virus Recombinant Hemagglutinin Protein Based ELISA for Sero-Surveillance

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Utility of Pandemic H1N1-09 Influenza Virus Recombinant Hemagglutinin Protein Based ELISA for Sero-Surveillance

    Clin Vaccine Immunol. 2010 Jul 14. [Epub ahead of print]
    Utility of Pandemic H1N1-09 Influenza Virus Recombinant Hemagglutinin Protein Based ELISA for Sero-Surveillance.

    Arankalle VA, Virkar RG, Tandale BV, Ingle NB.

    National Institute of Virology, 130/1, Sus Road, Pashan, Pune, India, 411021.
    Abstract

    Comparison of an ELISA for the detection of IgG antibodies against pandemic-H1N1-09 influenza virus employing recombinant hemagglutinin protein of the virus and hemagglutination-inhibition (HI) employing 783 sera showed concordance of 98.4% suggesting utility of ELISA in sero-surveillance. 269 (100%) sera with >/= 20 HI titer were ELISA reactive.

    PMID: 20631333 [PubMed - as supplied by publisher]

    An enzyme-linked immunosorbent assay (ELISA) for the detection of IgG antibodies against the pandemic H1N1 2009 influenza A virus, employing a recombinant hemagglutinin protein of the virus, was compared to the hemagglutination inhibition (HI) test using 783 serum samples. The results showed a conco …
Working...
X